Innovative therapeutics

Investors

SEC Filings

NASDAQBMRN
FormDescriptionDateFormat
DEF 14AOfficial notification to shareholders of matters to be brought to a vote ("Proxy")Apr 30, 2003View HTMLDownload DOCDownload PDFDownload XLS
PRE 14AA preliminary proxy statement providing notification matters to be brought to a voteApr 15, 2003View HTMLDownload DOCDownload PDFDownload XLS
424B2Form of prospectus filed in connection with primary offering of securities on a delayed basisApr 7, 2003View HTMLDownload DOCDownload PDF
8-KReport of unscheduled material events or corporate eventApr 1, 2003View HTMLDownload DOCDownload PDF
8-KReport of unscheduled material events or corporate eventMar 14, 2003View HTMLDownload DOCDownload PDF
424B2Form of prospectus filed in connection with primary offering of securities on a delayed basisMar 13, 2003View HTMLDownload DOCDownload PDF
10-KAnnual report which provides a comprehensive overview of the company for the past yearMar 3, 2003View HTMLDownload DOCDownload PDFDownload XLS
424B2Form of prospectus filed in connection with primary offering of securities on a delayed basisFeb 27, 2003View HTMLDownload DOCDownload PDF
8-KReport of unscheduled material events or corporate eventFeb 24, 2003View HTMLDownload DOCDownload PDFDownload XLS
8-KReport of unscheduled material events or corporate eventFeb 21, 2003View HTMLDownload DOCDownload PDFDownload XLS
424B5Form of prospectus disclosing information facts events covered in both forms 424B2 424B3Feb 21, 2003View HTMLDownload DOCDownload PDFDownload XLS
8-KReport of unscheduled material events or corporate eventFeb 10, 2003View HTMLDownload DOCDownload PDFDownload XLS
8-KReport of unscheduled material events or corporate eventFeb 6, 2003View HTMLDownload DOCDownload PDF
424B5Form of prospectus disclosing information facts events covered in both forms 424B2 424B3Feb 5, 2003View HTMLDownload DOCDownload PDFDownload XLS
8-KReport of unscheduled material events or corporate eventJan 29, 2003View HTMLDownload DOCDownload PDFDownload XLS
S-3/APre-effective amendment to an S-3 filingJan 17, 2003View HTMLDownload DOCDownload PDFDownload XLS
8-KReport of unscheduled material events or corporate eventJan 17, 2003View HTMLDownload DOCDownload PDF
SC 13G/AAmendment to a previously filed SC 13GJan 15, 2003View HTMLDownload DOCDownload PDF
1-25      26-50      51-68

BioMarin

Diseases

Lysosomal Storage Disorders (MPS I, MPS IVA, MPS VI, CLN2 disease) PKU, LEMS

Products

Palynziq™
Brineura™
Vimizim®
Kuvan®
Naglazyme®
Aldurazyme®
Firdapse®

Patient/Physician Support Contact Information

BioMarin RareConnections
Tel: 866.906.6100
Fax: 888.863.3361
E-mail: support@biomarin-rareconnections.com

Global Medical Information

Contact Global Medical Information